514 related articles for article (PubMed ID: 14640687)
1. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
2. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
3. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
[TBL] [Abstract][Full Text] [Related]
4. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
Havener JM; Nick McElhinny SA; Bassett E; Gauger M; Ramsden DA; Chaney SG
Biochemistry; 2003 Feb; 42(6):1777-88. PubMed ID: 12578393
[TBL] [Abstract][Full Text] [Related]
5. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
6. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
[TBL] [Abstract][Full Text] [Related]
7. The N2-ethylguanine and the O6-ethyl- and O6-methylguanine lesions in DNA: contrasting responses from the "bypass" DNA polymerase eta and the replicative DNA polymerase alpha.
Perrino FW; Blans P; Harvey S; Gelhaus SL; McGrath C; Akman SA; Jenkins GS; LaCourse WR; Fishbein JC
Chem Res Toxicol; 2003 Dec; 16(12):1616-23. PubMed ID: 14680376
[TBL] [Abstract][Full Text] [Related]
8. Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa.
Suzuki N; Yasui M; Santosh Laxmi YR; Ohmori H; Hanaoka F; Shibutani S
Biochemistry; 2004 Sep; 43(35):11312-20. PubMed ID: 15366941
[TBL] [Abstract][Full Text] [Related]
9. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Vaisman A; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
[TBL] [Abstract][Full Text] [Related]
10. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
Vaisman A; Chaney SG
J Biol Chem; 2000 Apr; 275(17):13017-25. PubMed ID: 10777605
[TBL] [Abstract][Full Text] [Related]
11. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
[TBL] [Abstract][Full Text] [Related]
12. Adduct size limits efficient and error-free bypass across bulky N2-guanine DNA lesions by human DNA polymerase eta.
Choi JY; Guengerich FP
J Mol Biol; 2005 Sep; 352(1):72-90. PubMed ID: 16061253
[TBL] [Abstract][Full Text] [Related]
13. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
14. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T
Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic properties of 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene, a persistent acetylaminofluorene-derived DNA adduct in mammalian cells.
Yasui M; Dong H; Bonala RR; Suzuki N; Ohmori H; Hanaoka F; Johnson F; Grollman AP; Shibutani S
Biochemistry; 2004 Nov; 43(47):15005-13. PubMed ID: 15554708
[TBL] [Abstract][Full Text] [Related]
16. DNA binding properties of human DNA polymerase eta: implications for fidelity and polymerase switching of translesion synthesis.
Kusumoto R; Masutani C; Shimmyo S; Iwai S; Hanaoka F
Genes Cells; 2004 Dec; 9(12):1139-50. PubMed ID: 15569147
[TBL] [Abstract][Full Text] [Related]
17. Specificity of platinum-DNA adduct repair.
Chaney SG; Vaisman A
J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
[TBL] [Abstract][Full Text] [Related]
18. Miscoding properties of 2'-deoxyinosine, a nitric oxide-derived DNA Adduct, during translesion synthesis catalyzed by human DNA polymerases.
Yasui M; Suenaga E; Koyama N; Masutani C; Hanaoka F; Gruz P; Shibutani S; Nohmi T; Hayashi M; Honma M
J Mol Biol; 2008 Apr; 377(4):1015-23. PubMed ID: 18304575
[TBL] [Abstract][Full Text] [Related]
19. Translesion synthesis past estrogen-derived DNA adducts by human DNA polymerases eta and kappa.
Suzuki N; Itoh S; Poon K; Masutani C; Hanaoka F; Ohmori H; Yoshizawa I; Shibutani S
Biochemistry; 2004 May; 43(20):6304-11. PubMed ID: 15147214
[TBL] [Abstract][Full Text] [Related]
20. Translesion synthesis past 2'-deoxyxanthosine, a nitric oxide-derived DNA adduct, by mammalian DNA polymerases.
Yasui M; Suzuki N; Miller H; Matsuda T; Matsui S; Shibutani S
J Mol Biol; 2004 Nov; 344(3):665-74. PubMed ID: 15533436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
